Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents
Gadolinium(III) complexes are strong enhancers of magnetic resonance imaging (MRI) signals, thus are widely used as contrast agents despite their potential toxicity. Here, the authors review ligand design approaches aimed at improving the stability of Gd(III)-based MRI contrast agents.
Enregistré dans:
Auteurs principaux: | Thomas J. Clough, Lijun Jiang, Ka-Leung Wong, Nicholas J. Long |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f20637c1e52446f1b3f9afd3a401fc33 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T1 relaxometry in patients with prostate cancer
par: Nikita Sushentsev, et autres
Publié: (2020) -
Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement
par: Scott D Swanson, et autres
Publié: (2008) -
PEG-modified gadolinium nanoparticles as contrast agents for in vivo micro-CT
par: Charmainne Cruje, et autres
Publié: (2021) -
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
par: Estelrich J, et autres
Publié: (2015) -
Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma
par: Patil R, et autres
Publié: (2020)